Protalix BioTherapeutics, Inc. (PLX)

NYSEAMERICAN: PLX · Real-Time Price · USD

2.410

+0.030 (1.26%)

At close: Aug 24, 2026, 4:00 PM EDT

2.410

0.00 (0.00%)

After-hours: Aug 24, 2026, 8:00 PM EDT

Protalix BioTherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	27.42	14.68	19.76	23.63	17.11	38.99
Short-Term Investments	13.24	15.59	15.07	20.93	5.07	-
Cash & Short-Term Investments	40.66	30.27	34.83	44.56	22.18	38.99
Cash Growth	21.73%	-13.08%	-21.84%	100.90%	-43.11%	1.14%
Accounts Receivable	16.5	8.84	2.91	5.27	4.59	3.44
Other Receivables	-	0.63	0.49	0.48	0.36	0.31
Receivables	16.5	9.47	3.4	5.75	4.95	3.75
Inventory	32.29	25.73	21.24	19.05	16.8	17.95
Prepaid Expenses	-	0.39	0.5	0.44	0.77	0.91
Other Current Assets	2.77	0.8	0.11	0.13	0.17	0.07
Total Current Assets	92.22	66.67	60.08	69.93	44.88	61.67
Property, Plant & Equipment	13.64	12.58	10.02	10.88	9.64	9.92
Long-Term Deferred Tax Assets	2.37	2.52	2.86	3.09	-	-
Other Long-Term Assets	2.1	0.58	0.46	0.53	1.27	2.08
Total Assets	110.34	82.35	73.42	84.43	55.79	73.67

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.51	5.26	4.53	4.32	5.86	6.99
Accrued Expenses	16.38	14.53	13.8	13.2	11.6	16.34
Current Portion of Long-Term Debt	-	-	-	20.25	-	-
Current Portion of Leases	1.67	1.38	1.5	1.41	1.12	1.21
Current Income Taxes Payable	4.22	2.95	3.48	2.88	0.53	-
Current Unearned Revenue	-	-	-	-	13.18	8.55
Other Current Liabilities	2.62	2.4	2.31	3.48	0.14	0.1
Total Current Liabilities	31.39	26.52	25.62	45.53	32.43	33.18
Long-Term Debt	-	-	-	-	28.19	27.89
Long-Term Leases	7.54	6.94	4.03	4.62	4.17	4.38
Long-Term Unearned Revenue	-	-	-	-	-	11.79
Pension & Post-Retirement Benefits	-	0.66	0.56	0.71	1.64	2.47
Total Liabilities	38.93	34.12	30.21	50.87	66.43	79.7

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.08	0.08	0.08	0.07	0.05	0.05
Additional Paid-In Capital	434.23	433.15	421.53	415.05	379.17	368.85
Retained Earnings	-362.9	-385	-378.39	-381.55	-389.86	-374.93
Shareholders' Equity	71.4	48.23	43.21	33.57	-10.64	-6.04
Total Liabilities & Equity	110.34	82.35	73.42	84.43	55.79	73.67

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	9.21	8.32	5.53	26.28	33.47	33.47
Net Cash (Debt)	31.45	21.95	29.3	18.28	-11.29	5.52
Net Cash Growth	12.12%	-25.09%	60.31%	-	-	-
Net Cash Per Share	0.39	0.28	0.36	0.22	-0.23	0.12
Filing Date Shares Outstanding	80.57	80.57	78.03	73.05	57.35	46.32
Total Common Shares Outstanding	80.57	80.43	75.85	72.95	53.79	45.56
Working Capital	60.83	40.16	34.46	24.4	12.45	28.49
Book Value Per Share	0.89	0.60	0.57	0.46	-0.20	-0.13
Tangible Book Value	71.4	48.23	43.21	33.57	-10.64	-6.04
Tangible Book Value Per Share	0.89	0.60	0.57	0.46	-0.20	-0.13
Machinery	-	23.86	22.42	22.02	21.32	20.96
Leasehold Improvements	-	18.07	17.91	17.64	16.92	16.76

SEC Filings: 10-K · 10-Q